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The role of sleep duration in diabetes and glucose control 1 
Abstract 2 
Sleep curtailment is common in the westernised world and coincides with an increase in the prevalence 3 
of Type 2 diabetes (T2DM). This review considers the recently published evidence for whether sleep 4 
duration is involved in the development of T2DM in humans and whether sleep has a role to play in 5 
glucose control in people who have diabetes. Data from large, prospective studies indicates a U-shaped 6 
relationship between sleep duration and the development of T2DM. Smaller, cross-sectional studies 7 
also support a relationship between short sleep duration and the development of both insulin resistance 8 
and T2DM. Intervention studies show that sleep restriction leads to insulin resistance, with recent sleep 9 
extension studies offering tantalising data showing a potential benefit of sleep extension on glucose 10 
control and insulin sensitivity. In people with established diabetes the published literature shows an 11 
association between poor glucose control and both short and long sleep duration. However, there are 12 
currently no studies that determine the causal direction of this relationship, nor whether sleep 13 
interventions are likely to offer benefit for people with diabetes to help them achieve tighter glucose 14 
control. 15 
Introduction 16 
Life on earth is governed by the 24-hour cycle of light and darkness associated with the rotation of the 17 
earth. Normally metabolic and physiological pathways are coordinated to this 24-hour cycle by an 18 
endogenous clock enabling our bodies to coordinate appropriate physiological processes to the time of 19 
day. Research in animals and humans suggests that the advent of a 24/7 lifestyle that disrupts our 20 
natural sleep cycles and their alignment to the external light/dark cycle is important in the regulation of 21 
energy balance and glucose metabolism (1; 2; 3). Sleep curtailment has become a prevalent behaviour in 22 
the Western and developing world where it is estimated that average sleep duration has declined by 23 
almost 2 hours in the past 50 years (4). In the USA and UK, a third of the population report getting less 24 
than 7 hours sleep per night(5; 6). Coinciding with this there has been an explosion in the prevalence of 25 
type 2 diabetes (T2DM), raising the important question of whether there is a causal link between the 26 
two. This review will specifically consider the recently published evidence for whether sleep duration 27 
is involved in the development of T2DM in humans. It will not appraise the considerable number of 28 
studies looking predominantly at the role of sleep in the development of obesity. Nor will it address the 29 
separate, but related, literature linking sleep related breathing disorders to obesity and T2DM. Having 30 
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considered the role of sleep duration per se in the development of diabetes, the evidence for whether 31 
sleep duration has a role to play in glucose control in people who have diabetes is reviewed.  32 
Association between sleep duration and the risk of T2DM 33 
Evidence from prospective studies  34 
Several large cohort studies have  investigated the association between sleep duration and the risk of 35 
subsequently developing T2DM, studied over varying lengths of follow-up(7; 8; 9; 10; 11; 12; 13; 14; 15; 16). 36 
Details of their study design and outcomes are shown in Table 1a. Several big studies in the USA and 37 
Germany have shown a U-shaped association between sleep duration and increased risk of T2DM(7; 8; 38 
9). The studies relied on subjective measures, with sleep duration self-reported at baseline, and T2DM 39 
incidence was mainly by self-report of physician’s diagnosis. Using 7 hours of sleep duration per night 40 
as a reference category, those with shorter and longer sleep duration were significantly more likely to 41 
develop T2DM  over the follow-up period of 5-15 years (risk estimates ranging  between 1.47-1.95 for 42 
short sleep duration, and between 1.40-3.12 for long sleep duration) . Regression models employed in 43 
the analysis were adjusted for many potential confounders, mainly; age, physical activity, BMI, alcohol 44 
consumption, ethnicity, education, marital status, depression and history of hypertension. Not all 45 
studies have shown this U-shaped relationship however. A large Australian study of >192,000 adults, 46 
used information recorded in medical insurance records (10) and reported a positive association between 47 
short (but not long) sleep duration and subsequent incidence of T2DM. However, T2DM incidence was 48 
determined from hospital admission records and so those who were not admitted to hospital during the 49 
follow-up period could not be identified as T2DM which might have led to underestimation of the 50 
actual diabetes incidence. In addition, the follow up period was relatively short (mean duration 2.3 51 
years). Another prospective study examined the association of sleep duration with development of 52 
impaired fasting glucose (IFG) over six years of follow-up (11), with 6-8 hour sleep duration as a 53 
reference category, short (but not long) sleepers had higher odds of developing IFG (OR 3.0, 95% CI 54 
1.05-8.59; OR 1.6, 95% CI 0.45-5.42: for short and long sleep duration respectively). Whereas a 55 
Finnish study in overweight individuals with impaired glucose tolerance found an increased risk of 56 
T2DM only in participants with long sleep duration ≥ 9 hours( HR 2.29, 95% CI 1.38–3.80)(14). Finally 57 
two recent meta-analyses of nine(17) and fourteen(18) prospective cohort studies have also confirmed the 58 
U-shaped relationship (Figure 1).A couple of other studies have investigated the association between 59 
short compared to normal sleep duration and the risk of T2DM without examining for a U-shaped 60 
relationship. The first showed that sleeping ≤7 hours per night was associated with higher odds of 61 
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developing T2DM after 6 years follow- (OR 1.96, 95% CI 1.10-3.50)(12). Models were adjusted for age, 62 
sex, physical activity, smoking habit, weight gain, and abnormal glucose regulation at baseline. The 63 
study also found that the odds of becoming obese were significantly higher in subjects who slept ≤7 64 
hours per night (OR 1.99, 95% CI 1.12-3.55). There was a lack of association between sleep duration 65 
and TD2M at 11 years follow-up that could be related to the attrition in study population over time and 66 
to the mediation effect exhibited by adjusting for weight gain in the model. The second study found a 67 
higher odds of T2DM after 2 years follow-up, sleeping ≤5 hours compared to >7 hours sleep duration 68 
(OR 5.37, 95% CI 1.38-20.91)(13). But the logistic regression models were adjusted for fasting plasma 69 
glucose, an integral feature of the outcome measure - T2DM. This leads to a statistical phenomenon 70 
known as mathematical coupling thus rendering the result spurious (19; 20).  71 
 72 
Figure 1. U-shaped relationship between sleep duration and risk of T2DM (adapted from Shan, Ma et al. 73 
2015(17)) 74 
 75 
Extending the understanding of the relationship between sleep duration and risk of T2DM the impact of 76 
a change in sleep duration over time has also been investigated. In the Whitehall II study in the UK, 77 
change in sleep duration was calculated for participants without diabetes at the beginning and end of 78 
four 5-year cycles and T2DM incidence was observed at the end of the subsequent cycle(15).Another, 79 
rather convoluted, prospective study (the Nurses' Health Study) examined whether historic changes in 80 
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women’s sleep duration over the preceding 14 years was associated with developing T2DM over the 81 
subsequent 12 year follow up (16). In both studies logistic regression models showed higher risk of 82 
developing T2DM in participants with chronic short sleep duration (≤5.5-6 hours) (Whitehall II study: 83 
OR 1.35, 95% CI 1.04- 1.76; Nurses' Health Study: HR 1.10, 95%CI 1.001, 1.21 )  and in those with an 84 
increase of ≥2 hours sleep duration (Whitehall II study: OR 1.65 , 95% CI 1.15- 2.37; Nurses' Health 85 
Study: HR 1.15, 95% CI 1.01- 1.30) compared to those who maintained a 7-8 hour sleep duration. 86 
After adjusting for body mass index (BMI) both associations were attenuated, suggesting that BMI is a 87 
mediator in the association. These studies suggest that the adverse metabolic influence of short sleep 88 
duration may not be ameliorated by increasing sleep duration later in life.   89 
Taken together, these large, prospective studies which include both men and women, and a wide range 90 
of ages, show that a U-shaped relationship exists between self-reported sleep duration and the 91 
development of T2DM. Given the increasing societal pressures to sleep less this data is very persuasive 92 
of short sleep duration being implicated in the co-existent T2DM epidemic.  93 
Evidence from cross- sectional studies  94 
Whilst they do not carry the same weight as prospective studies, there have been several recent cross-95 
sectional studies that suggest there may be some key sociodemographic factors that influence the 96 
relationship between sleep duration and T2DM, and these are summarised in Table 1-b. Again a U-97 
shaped association between sleep duration (over a 24 hour period) and T2DM was observed in 130,943 98 
adults, aged 18-85 years, using data from the National Health Interview Survey (NHIS) from 2004 to 99 
2011 (21). However, short and long sleep durations were more strongly associated with T2DM in white 100 
participants than in black. Adjustment for socioeconomic status and other health behavioural factors 101 
attenuated the associations in both groups and remained significant only in white participants. An 102 
additional cross-sectional study using the NHIS data, from years 2004-2005, also reported a U-shaped 103 
association between sleep duration and T2DM (22). A Chinese study showed that longer sleep duration 104 
over a 24 hour period was positively associated with having the metabolic syndrome and T2DM, but 105 
only in women. (23). Objectively measured sleep duration (using wrist actigraphy) showed a significant 106 
association between shorter sleep duration and having IFG and diabetes, but did not find any ethnic 107 
differences in a multi ethnic study (24).  108 
Association between sleep duration and the risk of insulin resistance   109 
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One of the key features of T2DM is impaired insulin mediated glucose uptake, otherwise known as 110 
insulin resistance. This precedes the glucose abnormalities and clinical manifestation of T2DM, often 111 
by many years. A selection of both observational and intervention studies have recently explored the 112 
relationship between sleep duration and measures of insulin resistance and these are summarised in 113 
Table 2.  114 
Evidence from cross sectional studies 115 
A small study compared self-reported sleep duration in insulin-resistant individuals (n= 35) with that 116 
seen in insulin-sensitive individuals (n=21). Those with insulin resistance slept 43 minutes less/night 117 
(p-value = 0.018). The study also found that 60% of insulin-resistant participants slept less than 7 hours 118 
in comparison to only 24% only of insulin-sensitive participants (p-value 0.013), though no adjustment 119 
for potential confounders was performed (25).   120 
Whilst observational studies are of interest, it is well designed interventional studies that really help us 121 
to understand the role of sleep duration in the development of insulin resistance and glucose tolerance. 122 
There have been a cluster of these published recently looking at the metabolic effects of both sleep 123 
restriction and sleep extension. 124 
Evidence from sleep restriction clinical studies 125 
Multiple small lab-based crossover studies on healthy young participants have looked at the effect of 126 
sleep restriction on insulin sensitivity and glucose tolerance (26; 27; 28; 29; 30). Sleep restriction was 127 
associated with reduced insulin sensitivity in all the studies (except one(30) ), with reduced glucose 128 
tolerance in one of them (27). The study that found no effect on glucose or insulin aimed to determine 129 
the hormonal effects of restricting sleep duration under controlled feeding conditions (30). A controlled 130 
diet was provided and the participants lost weight in both the habitual and short sleep phases. It is 131 
possible that  in the context of negative energy balance, acute short sleep duration does not lead to a 132 
state of increased insulin resistance. These studies were all performed in controlled laboratory based 133 
environments and explored acute and often severe sleep restriction. One  recent study has examined 134 
participants in their home environment to determine if milder and more chronic sleep restriction, akin 135 
to daily life, has a role to play (31). Nineteen healthy, young, normal-weight men with habitual sleep 136 
durations of 7.0–7.5 hours and no sleep disturbances were randomised to either study arm (1.5 hours 137 
reduction in habitual bedtime) or control arm (habitual bedtime) for three weeks. Sleep restriction led 138 
to a decrease in insulin sensitivity at the end of first week but then recovered to baseline levels.  139 
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In summary these intervention studies are showing that sleep restriction is associated with the 140 
development of insulin resistance and impairment of glucose tolerance. Whether these effects are short 141 
lived adaptive responses to an acute stress, or whether they persist longer term and contribute to the 142 
risk of T2DM remains unclear. 143 
Evidence from sleep extension clinical studies  144 
Given that short sleep duration and sleep restriction are linked to the development of insulin resistance 145 
it is timely that a couple of studies are starting to address whether sleep extension has beneficial effects 146 
on insulin and glucose metabolism. 147 
The first, a crossover study (32) showed that whilst insulin sensitivity deteriorates after acute  sleep 148 
restriction it recovers after two days of catch-up sleep. Under lab-controlled conditions participants had 149 
up to 8.5 hours of sleep per night for 4 consecutive nights and up to 4.5 hours of sleep for another 4 150 
consecutive nights in a randomised order. After the nights of restricted sleep participants had 2 ‘catch-151 
up’ nights of 10-12 hours of sleep. Participants had a 23% decrease in insulin sensitivity after 4 days of 152 
sleep curtailment compared to normal sleep. However, insulin sensitivity was restored after 2 days of 153 
catch-up sleep. Although the study showed that catch-up sleep may reverse the negative impact of 154 
short-term sleep deprivation, the long-term impact of a repeated sleep deprivation and catch-up sleep 155 
cycles on diabetes risk is not known.  156 
The second study investigated whether sleep extension in the home environment has a positive impact 157 
on glucose metabolism in healthy adults with chronic sleep curtailment (33). Sixteen young healthy non-158 
obese adults, mostly females, had two weeks of habitual time in bed followed by 6 weeks of one hour 159 
per day extension time in bed. Glucose and insulin were assayed at the end of the two periods. During 160 
the intervention phase; participants mostly went to bed an hour earlier and had higher sleep duration 161 
during weekdays but maintained the same sleep duration during weekends. The study indicated no 162 
significant difference between pre- and post-intervention fasting glucose and insulin levels, though no 163 
statistics were shown (34). A moderate linear relationship was reported between the relative change in 164 
sleep duration and the relative change in fasting glucose (r = +0.65, P = 0.017) and insulin levels (r = 165 
−0.57, P = 0.053), however we cannot quantify these relationships nor state if they were statistically 166 
significant, without a reported estimate measure of associations.  167 
In conclusion, these sleep extension studies, offer tantalising data supporting a potential benefit of sleep 168 
extension on glucose control and insulin sensitivity. Much more work is clearly needed in this area. 169 
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Association between sleep duration and glycaemic control in patients with diabetes  170 
Given the mounting evidence supporting a relationship between sleep duration and the development of 171 
insulin resistance and T2DM, it is relevant to consider whether sleep duration has an impact on 172 
glycaemic control in people with established diabetes. Most studies to date are cross sectional with 173 
sample size ranging from as low as 18 participants to as high as 8543 participants, and these are 174 
summarised in Table 3. Most of these studies assessed glycaemic control using HbA1c except one that 175 
used capillary glucose levels (35). Sleep parameters were mainly self-reported except for three studies 176 
that measured sleep objectively using wrist actigraphy (35; 36; 37).  177 
Evidence from cross-sectional studies using subjectively reported sleep duration 178 
Okhuma et al showed that shorter and longer sleep durations were associated with a higher HbA1c 179 
level compared with a sleep duration of 6.5–7.4 hours in T2DM patients (Figure 2)(38). Sleep duration 180 
including naps was self–reported. This U-shaped association was not attenuated after adjusting for 181 
BMI, total energy intake and depressive symptoms. A similar U-shaped relation was reported in a large 182 
Korean study which included participants with both T1DM and T2DM (39). The association between 183 
short sleep duration and poor glycaemic control was strongest for females and participants below the 184 
age of 65 years. However, these associations was attenuated after adjusting for BMI and waist 185 
circumference and no association was observed after further adjustment for treatment status, duration 186 
of diabetes, and daily caloric intake. On the other hand, only longer sleep duration was associated with 187 
poor glycaemic control in T2DM patients in a large Chinese (40) and a smaller Taiwanese study (41). 188 
Perceived sleep debt  but not sleep duration was positively associated with HbA1c in African 189 




Figure 2. Higher HbA1c observed in shorter and longer sleep duration in Japanese T2DM compared to 192 
6.5–7.4 hour sleep duration(*P < 0.05; **P < 0.01 ), adapted from Okhuma, T et al. 2013 (38) 193 
 194 
Evidence from cross-sectional studies using objectively measured sleep duration 195 
Using wrist actigraphy to objectively measure sleep parameters for three consecutive days in the home 196 
environment Trento et al. found no difference in sleep duration between T2DM and control subjects 197 
(36). T2DM sleep quality was found to correlate slightly with glycaemic control, while no correlation 198 
with sleep duration was reported. On the other hand, Borel et al. shown that T1DM patients with 199 
shorter sleep duration (< 6.5 hours) had a higher HbA1c than those with longer sleep duration (> 6.5 200 
hours), (mean 8.5% vs. mean 7.7%; p-value = 0.001) (37). In an adjusted regression model shorter sleep 201 
duration was associated with 0.64% increase in mean HbA1c level compared to longer sleep duration 202 
but no 95% CI or p-value were reported. Participants with short sleep duration were also more likely to 203 
have obstructive sleep apnoea and as this was not considered in the analysis, part of the difference 204 
reported could be attributed to it. 205 
Lastly Barone et al. assessed the association between objectively measured sleep parameters using 206 
wrist actigraphy and glycemic control using capillary glucose levels from glucometer in a group of 18 207 
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young adults with T1DM (35). They showed a positive correlation between the average amount of rest at 208 
night and both average glucose levels (r = 0.5404; p-value = 0.0697) and glycemic variability (r = 209 
0.5706; p-value = 0.0527). No estimate measure of the association nor adjustment for any potential 210 
confounders were made. Moreover, the average night rest duration was calculated from 10 days 211 
actigraphy which may have included two weekends for some participants and only one weekend for 212 
others, and thus it will be inevitably incomparable between participants. 213 
In summary, in people with diabetes there also appears to be evidence of an association between both 214 
short and long sleep duration and worse glucose control. However, these studies are cross-sectional and 215 
so evidence of causality cannot be inferred. A complicating factor when interpreting the relationship 216 
between glucose and sleep in people with diabetes is that extremely poor glucose control is well 217 
recognised to cause polyuria, polydypsia and nocturia meaning they are awake during the night. 218 
Reverse causality cannot be excluded in these studies as they do not distinguish the severity of glucose 219 
control and are likely to include participants experiencing some of these osmotic symptoms. 220 
Randomised clinical trials with exposure to sleep duration modification (restriction or extending) and 221 
robust methods of assessing temporal glucose across the 24 hour day and night (43)  are needed to yield 222 
more definitive answers. 223 
Conclusions 224 
The recently published literature of both observational and interventional studies strongly supports a 225 
role for both short and long sleep duration in the development of insulin resistance and T2DM. There 226 
are insufficient sleep intervention studies to determine whether this risk is modifiable long term. In 227 
people with established diabetes the published literature supports an association between poor glucose 228 
control and both short and long sleep duration. However, there are no studies that determine the causal 229 
direction of this relationship in people with diabetes nor whether sleep interventions may offer benefit 230 
in achieving glucose control. This is a fertile field for future research.  231 
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Table 1-a: Prospective studies on sleep duration and the risk of developing T2DM. 
Author, year country participant Study design exposure outcome result comment 
Gangwisch et al., 
2007(8) 
USA 8992 adult aged 32-68 





nighttime  sleep 
duration 
T2DM incidence 





Yaggi et al., 
2006(7) 
USA 1564 men aged 40-70 
years from the 
Massachusetts Male 












Kowall et al., 
2016(9) 
Germany 4814 adults aged 45-
75 years from the 













Holliday et al., 
2013(10) 
Australia 192728 adults aged ≥ 








over a mean follow 




only short sleep 
duration 
Diabetes incidents extracted 
from hospital admission or 
mortality electronic records, 
short follow up period 
Rafalson et al., 
2010(11) 
USA 363 participants; 91 
cases, 272 controls, 










only short sleep 
duration 
 
Tuomilehto et al., 
2009(14) 
Finland 522 participants aged 
40–64 years without 
diabetes randomly 
allocated either to a 















only long sleep 
duration 
Only in the control arm cohort 
Gutiérrez-Repiso 
et al., 2014(12) 
Spain 1145 randomly 
selected participants 
aged 16-65 years from 






T2DM incidence at 




at 6 year follow 
up 
Change in sleep duration over 
the 11 year follow up 
Kita et al., 
2012(13) 
Japan 3570 adults aged 35-















Ferrie et al., 
2015(15) 
UK 5613 adults aged 35-
55 years from the 






duration in the 
following cycle 
T2DM incidence at 




increase ≥ 2 
hours 
Association could be mediated 
by weight gain 
Cespedes et al., 
2016(16) 
USA 59031 middle aged to 




Change in sleep 
duration over 14 
years  
T2DM incidence 
over  12 year 
follow up period 
Positive 
association, 
increase ≥ 2 
hours 
Association only with increase 
in sleep duration ≥ 2 h/day, 
Change in sleep duration from a 
historic baseline to time of 
enrolment 
 
Table 1-b: Cross-sectional studies on sleep duration and the risk of developing T2DM. 
Author, year country participant Study design exposure outcome result comment 
Jackson et al., 
2013(21) 
USA 130,943 adults 
aged 18-85 years 
from the NHIS 





duration in a 24 
hours period 
self-reported T2DM status  U-shaped 
associations 





USA 56507 adults 
from the NHIS 





duration in a 24 
hours period 
self-reported chronic 
diseases including T2DM 
U-shaped 
associations 
multilevel logistic regression 
Wu et al., 
2015(23) 
China 25184 adults 
mean age 63 








Risk of metabolic 
syndrome including 
T2DM 
No association with 
nighttime sleep 
duration 
Positive association with 
daytime napping duration 
Bakker et al., 
2015(24) 
USA 2151 participant 
aged 45-84 years 
from the Multi-










Table 2: Studies on sleep duration and development of insulin resistance  
Author, year country participant Study design exposure outcome result comment 
Liu et al., 
2013(25) 







Insulin sensitivity Positive association Only P-values reported. 
Broussard et 
al., 2012(26) 




Sleep restriction Insulin sensitivity Positive association  
Nedeltcheva et 
al., 2009(27) 





Sleep restriction Insulin sensitivity 
and glucose 
tolerance 
positive association  
Wang et al., 
online 2016(28) 






restriction by 1 to 








No association with glucose 
tolerance 






age 44.6 years 
Crossover 
clinical study 
Sleep restriction Insulin sensitivity Positive association  
St-Onge et al., 
2012(30) 




Time in bed 
restricted to 4 
hours 
insulin sensitivity No association Participants had controlled diet 
and lost weight during the study 
Robertson et 
al., 2013(31) 




Around 1.5 hours 
sleep restriction 
per night for 3 
weeks 
insulin sensitivity Positive association 
only at the end of 
first week 
absence of an overall effect of 












Positive association  
Leproult et al., 
2015(33) 
Belgium 16 healthy young 
non-obese adults 




Around one hour 
sleep extension 
per night for 6 
weeks 
Fasting glucose 
and insulin levels 
No difference in pre- 
and post- 
intervention levels 
Moderate correlation between 
relative change in sleep duration 
and relative change in fasting 




Table 3: Studies on sleep and glycemic control in patients with diabetes  
Author, year country participant Study design exposure outcome result comment 
Ohkuma et 
al., 2013(38) 
Japan 4870 adults, aged 












Kim et al., 
2013(39) 
Korea 2134 adults, aged > 
20 years with 









J-shaped trend with HbA1c; stronger in 
females and in the younger age group (<65 
years). Association disappear after 
adjusting for more covariate in the logistic 
regression model. 
Zheng et al., 
2015(40) 
China 8543 adults, aged 
≥40 years with 














Only adjusted means and p-values reported 
but no estimate of association 
Tsai et al., 
2012(41) 
Taiwan 46 adults, aged 43-











Participants with diabetic complication or 
major co-morbidities were excluded. 
association only with sleep efficiency and 






















Sleep debt association only in participants 
without diabetic complication or not using 
insulin. sleep quality only in participants 
with diabetic complication or using insulin 
association  
Trento et al., 
2008(36) 
Italy 47 middle aged 
adults with T2DM 








quality using wrist 
actigraphy 
glycemic control 




Weak negative correlation with sleep 
efficiency and mild positive correlation 
with moving time while asleep. No estimate 
measures of association reported 
Borel et al., 
2013(37) 
France 79 adults, median 













Barone et Brazil 18 young adult, Cross Objective sleep Glycemic control No Methodological issues 
14 
 
al., 2015(35) aged 20-38 years 
with T1DM 
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